MedinCell S.A. (EPA:MEDCL)

MedinCell Statistics

Total Valuation

MedinCell has a market cap or net worth of EUR 746.80 million. The enterprise value is 766.89 million.

Market Cap	746.80M
Enterprise Value	766.89M

Important Dates

The next estimated earnings date is Tuesday, June 16, 2026.

Earnings Date	Jun 16, 2026
Ex-Dividend Date	n/a

Share Statistics

MedinCell has 33.10 million shares outstanding. The number of shares has increased by 8.92% in one year.

Current Share Class	33.10M
Shares Outstanding	33.10M
Shares Change (YoY)	+8.92%
Shares Change (QoQ)	+9.66%
Owned by Insiders (%)	12.52%
Owned by Institutions (%)	22.27%
Float	25.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	201.25
PS Ratio	23.02
PB Ratio	-24.38
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-38.44
EV / Sales	23.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-43.38

Financial Position

The company has a current ratio of 2.88

Current Ratio	2.88
Quick Ratio	2.83
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-4.16
Interest Coverage	-1.84

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-9.16%
Return on Invested Capital (ROIC)	-21.03%
Return on Capital Employed (ROCE)	-18.36%
Weighted Average Cost of Capital (WACC)	9.62%
Revenue Per Employee	223,717
Profits Per Employee	-137,572
Employee Count	145
Asset Turnover	0.49
Inventory Turnover	n/a

Taxes

In the past 12 months, MedinCell has paid 37,000 in taxes.

Income Tax	37,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +40.82% in the last 52 weeks. The beta is 1.05, so MedinCell's price volatility has been similar to the market average.

Beta (5Y)	1.05
52-Week Price Change	+40.82%
50-Day Moving Average	26.55
200-Day Moving Average	22.01
Relative Strength Index (RSI)	36.01
Average Volume (20 Days)	139,889

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedinCell had revenue of EUR 32.44 million and -19.95 million in losses. Loss per share was -0.63.

Revenue	32.44M
Gross Profit	32.44M
Operating Income	-9.78M
Pretax Income	-19.91M
Net Income	-19.95M
EBITDA	-9.57M
EBIT	-9.78M
Loss Per Share	-0.63

Balance Sheet

The company has 53.50 million in cash and 73.59 million in debt, with a net cash position of -20.09 million or -0.61 per share.

Cash & Cash Equivalents	53.50M
Total Debt	73.59M
Net Cash	-20.09M
Net Cash Per Share	-0.61
Equity (Book Value)	-30.63M
Book Value Per Share	-0.93
Working Capital	40.02M

Cash Flow

In the last 12 months, operating cash flow was -16.90 million and capital expenditures -782,000, giving a free cash flow of -17.68 million.

Operating Cash Flow	-16.90M
Capital Expenditures	-782,000
Free Cash Flow	-17.68M
FCF Per Share	-0.53

Margins

Gross margin is 100.00%, with operating and profit margins of -30.14% and -61.49%.

Gross Margin	100.00%
Operating Margin	-30.14%
Pretax Margin	-61.38%
Profit Margin	-61.49%
EBITDA Margin	-29.50%
EBIT Margin	-30.14%
FCF Margin	n/a

Dividends & Yields

MedinCell does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.92%
Shareholder Yield	-8.92%
Earnings Yield	-2.67%
FCF Yield	-2.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MedinCell has an Altman Z-Score of 3.26 and a Piotroski F-Score of 3.

Altman Z-Score	3.26
Piotroski F-Score	3